Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors

Completed

• Conditions: Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators

• Registration Number: NCT01356706
• Lead Sponsor: University Hospital, Gasthuisberg

Brief Summary

Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-10
• Primary Completion: 2008-12
• Study First Submitted: 2011-05-17
• Study First Submitted QC: 2011-05-17
• Study First Posted: 2011-05-19
• Status Verified: 2012-07
• Study Completion: 2012-07
• Last Update Submitted: 2012-07-01
• Last Update Posted: 2012-07-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 274

Inclusion Criteria

• Patients with CRLM
• Surgery: resection and/or ablation
• preoperative chemotherapy and/or biological agents are allowed
• postoperative chemotherapy and/or biological agents are allowed
• simultaneous colorectal resection is allowed

Exclusion Criteria

• primary liver cancer
• benign liver tumors
• pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
overall survival	5 years

Secondary Outcome Measures

Name	Time	Method
prognostic variables	5 year

Trial Locations

Locations (1)

University Hospitals Leuven KUL; 🇧🇪 Leuven, Vlaams-Brabant, Belgium